Tuberculosis is common among patients with HIV. Therefore, the authors of a new study set out to find a point-of-care test that can screen for TB quickly and accurately.
While it is known that disease progression of HIV-1 is delayed by HIV-2 in coinfected individuals, authors of a new study sought to identify the protective mechanisms of the coinfection.
To better understand immune reconstitution in children with HIV taking antiretroviral therapy, researchers compared immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
While neurocognition can increasingly decline with age among individuals with HIV, researchers of a study presented at CROI 2019 determined which factors are connected with neurocognitive decline in the...
As effective HIV interventions have been identified, the design and interpretation of HIV prevention trials has evolved. David Dunn, from University College London, explained these changes during CROI...
Researchers designed a survey to determine whether pregnant women with HIV knew their partner’s HIV status, their prevention or treatment plan, and if they had health insurance.
